<description>&lt;p&gt;Welcome to a RealTalk MS special series on MS clinical trials. This special series is made possible through a generous grant from Sanofi.&lt;/p&gt; &lt;p&gt;In &lt;em&gt;today's&lt;/em&gt; episode, you'll meet two participants from the TEAMS Study, a research study at the University of Illinois Chicago's UI Health, in conjunction with the University of Alabama Birmingham School of Public Health.&lt;/p&gt; &lt;p&gt;&lt;span class="align-left"&gt;TEAAMS is an acronym for Targeted Exercise for African-Americans with Multiple Sclerosis. And the study's research team analyzed the effects of a remotely delivered, racially tailored exercise training program among African Americans with MS living in low-income areas of the Southeastern United States, including Alabama, Georgia, Mississippi, North Carolina, South Carolina, Louisiana, Arkansas, and Tennessee. This is a part of the country that doesn't have many primary care or MS clinics that provide full exercise and rehabilitation services for patients with MS.&lt;/span&gt;&lt;/p&gt; &lt;p align="center"&gt;&lt;img src= "//assets.libsyn.com/show/105901/TEAAMS-20251119-9izs74ciyz.png" alt="TEAAMS Study" width="323" height="318" /&gt;&lt;/p&gt; &lt;p&gt;The TEAMMS study consists of two 16-week exercise programs, completed 3 days per week at home. One exercise program combines aerobic and resistance training, while the other focuses on stretching and flexibility. Study participants were randomly assigned to one of the two programs, and all of the materials to complete each program, like yoga mats, resistance bands, and training manuals, were provided. And every study participant receives a $90 gift card in compensation for completing the program.&lt;/p&gt; &lt;p&gt;The study's research team hypothesizes that completing the TEAAMS program would improve walking, reduce symptoms of fatigue, anxiety, depression, and pain, and enhance quality of life.&lt;/p&gt; &lt;p&gt;This special episode of RealTalk MS is made possible by a generous grant from Sanofi. Sanofi has two ongoing Phase 3 clinical trials in MS studying &lt;strong&gt;Frexalimab&lt;/strong&gt;, an investigational second-generation anti-CD40 ligand monoclonal antibody. If you are interested in learning more about these clinical trials, please visit &lt;strong&gt;&lt;a href= "https://sanofistudies.com" target="_blank" rel= "noopener"&gt;&lt;span style= "color: #e67e23;"&gt;SanofiStudies.com&lt;/span&gt;&lt;/a&gt;&lt;/strong&gt;&lt;/p&gt; &lt;div align="center"&gt; &lt;hr width="25%" /&gt;&lt;/div&gt; &lt;p style="text-align: center;"&gt;&lt;span style= "color: #e67e23;"&gt;&lt;strong&gt;SHARE THIS EPISODE OF REALTALK MS&lt;/strong&gt;&lt;/span&gt;&lt;/p&gt; &lt;p&gt;Just copy this link &amp; paste it into your text or email: &lt;a href="https://realtalkms.com/ct3" target="_blank" rel= "noopener"&gt;&lt;strong&gt;&lt;span style= "color: #e67e23;"&gt;https://realtalkms.com/ct3&lt;/span&gt;&lt;/strong&gt;&lt;/a&gt;&lt;/p&gt; &lt;p style="text-align: center;"&gt;&lt;span style= "color: #e67e23;"&gt;&lt;strong&gt;ADD YOUR VOICE TO THE CONVERSATION&lt;/strong&gt;&lt;/span&gt;&lt;/p&gt; &lt;p&gt;I've always thought about the RealTalk MS podcast as a conversation. And this is &lt;em&gt;your&lt;/em&gt; opportunity to join the conversation by sharing your feedback, questions, and suggestions for topics that we can discuss in future podcast episodes. Please shoot me an email or call the &lt;em&gt;RealTalk MS Listener Hotline&lt;/em&gt; and share your thoughts!&lt;/p&gt; &lt;p&gt;&lt;span style="color: #e67e23;"&gt;&lt;strong&gt;Email: &lt;a style= "color: #e67e23;" href="mailto:jon@realtalkms..com" target="_blank" rel= "noopener noreferrer"&gt;jon@realtalkms.com&lt;/a&gt;&lt;/strong&gt;&lt;/span&gt;&lt;br /&gt; &lt;span style="color: #e67e23;"&gt;&lt;strong&gt;Phone: (310) 526-2283&lt;/strong&gt;&lt;/span&gt;&lt;/p&gt; &lt;p&gt;And don't forget to join us in the &lt;span style= "color: #e67e23;"&gt;&lt;strong&gt;&lt;a style="color: #e67e23;" href= "https://facebook.com/groups/realtalkms"&gt;RealTalk MS Facebook group&lt;/a&gt;&lt;/strong&gt;&lt;/span&gt;!&lt;/p&gt; &lt;div align="center"&gt; &lt;hr width="25%" /&gt;&lt;/div&gt; &lt;div align="center"&gt; &lt;p&gt;&lt;span style="color: #d35400;"&gt;&lt;a style="color: #d35400;" href= "https://realtalkms.com/privacy-policy" target="_blank" rel= "noopener noreferrer"&gt;&lt;strong&gt;&lt;span style="color: #e67e23;"&gt;Privacy Policy&lt;/span&gt;&lt;/strong&gt;&lt;/a&gt;&lt;/span&gt;&lt;/p&gt; &lt;/div&gt;</description>

RealTalk MS

Jon Strum

Special Episode: Participating in MS Research with Chiquita Shepard-Knight and Earl Sneed

NOV 20, 202516 MIN
RealTalk MS

Special Episode: Participating in MS Research with Chiquita Shepard-Knight and Earl Sneed

NOV 20, 202516 MIN

Description

Welcome to a RealTalk MS special series on MS clinical trials. This special series is made possible through a generous grant from Sanofi.

In today's episode, you'll meet two participants from the TEAMS Study, a research study at the University of Illinois Chicago's UI Health, in conjunction with the University of Alabama Birmingham School of Public Health.

TEAAMS is an acronym for Targeted Exercise for African-Americans with Multiple Sclerosis. And the study's research team analyzed the effects of a remotely delivered, racially tailored exercise training program among African Americans with MS living in low-income areas of the Southeastern United States, including Alabama, Georgia, Mississippi, North Carolina, South Carolina, Louisiana, Arkansas, and Tennessee. This is a part of the country that doesn't have many primary care or MS clinics that provide full exercise and rehabilitation services for patients with MS.

The TEAMMS study consists of two 16-week exercise programs, completed 3 days per week at home. One exercise program combines aerobic and resistance training, while the other focuses on stretching and flexibility. Study participants were randomly assigned to one of the two programs, and all of the materials to complete each program, like yoga mats, resistance bands, and training manuals, were provided. And every study participant receives a $90 gift card in compensation for completing the program.

The study's research team hypothesizes that completing the TEAAMS program would improve walking, reduce symptoms of fatigue, anxiety, depression, and pain, and enhance quality of life.

This special episode of RealTalk MS is made possible by a generous grant from Sanofi. Sanofi has two ongoing Phase 3 clinical trials in MS studying Frexalimab, an investigational second-generation anti-CD40 ligand monoclonal antibody. If you are interested in learning more about these clinical trials, please visit SanofiStudies.com

SHARE THIS EPISODE OF REALTALK MS

Just copy this link & paste it into your text or email: https://realtalkms.com/ct3

ADD YOUR VOICE TO THE CONVERSATION

I've always thought about the RealTalk MS podcast as a conversation. And this is your opportunity to join the conversation by sharing your feedback, questions, and suggestions for topics that we can discuss in future podcast episodes. Please shoot me an email or call the RealTalk MS Listener Hotline and share your thoughts!

Email: [email protected] Phone: (310) 526-2283

And don't forget to join us in the RealTalk MS Facebook group!

Privacy Policy